Since cyclin D1 is associated with a favourable prognosis in breast cancer (Barnes and Gillett, 1998) and Rb and p16 are well-known tumour-suppressor genes, these results underline that ERK1 and ERK2 are not involved in proliferation in mammary carcinomas. This evidence concerns the gene MAPK3 and breast cancer.